Advertisement

Topics

Auriga Partners Company Profile

14:18 EST 20th November 2017 | BioPortfolio

Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences.
Enterprise creation represents the core activity of the Auriga's founding members since 1986. Our experienced management team of eight complements one another in education, experience, and sector specialization.

Along with investing the necessary capital, we also bring our savoir-faire in developing and solidifying the executive team, organizing the company, and forming strategic and corporate partnerships.

As investors, we actively contribute to defining the appropriate financial strategy, as well as, assisting our portfolio companies in raising future capital.

We are dedicated to providing a broad network of contacts capable of accelerating internationalization, and furthering strategic partnerships and business deals

Location

18, avenue Matignon
Paris
75008
France

Contact

Phone: 33 (0)1 53 30 07 07
Fax: 33 (0)1 53 30 07 00
Email: auriga@aurigapartners.com


News Articles [98 Associated News Articles listed on BioPortfolio]

Managing post-amputation pain with neurostimulation, Neuros Medical raises $20M

U.S. Venture Partners led the round with participation from Boston Scientific, Aperture Venture Partners, Osage University Partners, and JumpStart.

Partners Healthcare Closed $171M Innovation Fund for Life Sciences Startups

Partners HealthCare System has closed a $171 million innovation fund to invest in early stage life sciences startups. The innovation fund includes $66.1 million in outside capital for Partners Innovat...

Partners HealthCare raises $171M for second innovation fund for healthcare startups (Updated)

Partners Innovation Fund II will invest in 15-20 companies, according to Roger Kitterman, Vice President of Partners Innovation. It will be particularly aggressive in gene therapy.

MorphoSys-Aktie: Shortseller AHL Partners zieht sich weiterhin zurück - Aktiennews

Martinsried - Leerverkäufer AHL Partners LLP baut Netto-Leerverkaufsposition in MorphoSys-Aktien signifikant ab: Die Leerverkäufer von AHL Partners LLP haben sich aus ihrem Short-Engagement in den ....

Evotec-Aktie bleibt unter Beschuss von Leerverkäufer AHL Partners! Aktiennews

Hamburg - Leerverkäufer AHL Partners LLP stockt Netto-Leerverkaufsposition in Aktien der Evotec AG weiter sichtbar auf: Die Leerverkäufer von AHL Partners LLP befinden sich kontinuierlich im Attack....

MorphoSys-Aktie: Shortseller AHL Partners reduziert Shortposition - Aktiennews

Martinsried - Leerverkäufer AHL Partners LLP reduziert Netto-Leerverkaufsposition in MorphoSys-Aktien moderat: Die Leerverkäufer von AHL Partners LLP haben ihr Short-Engagement in den Aktien des Bi....

Evotec-Aktie: Leerverkäufer AHL Partners zieht sich weiter deutlich zurück - Aktiennews

Hamburg - Leerverkäufer AHL Partners LLP reduziert Netto-Leerverkaufsposition in Aktien der Evotec AG wieder deutlich: Die Leerverkäufer von AHL Partners LLP bleiben auf dem Rückzug aus ihrem Short...

Evotec-Aktie: Leerverkäufer AHL Partners bleibt im Rückwärtsgang - Aktiennews

Hamburg - Leerverkäufer AHL Partners LLP reduziert Netto-Leerverkaufsposition in Aktien der Evotec AG wieder: Die Leerverkäufer von AHL Partners LLP bleiben im Rückwärtsgang heraus aus ihrem Short...

Drugs and Medications [21 Associated Drugs and Medications listed on BioPortfolio]

Sweatblock [DC Alpine Partners, LLC DBA: Sweatblock]

SWEATBLOCK Clinical Strength Antiperspirant

Day cream mattifying hydrator [MOSAIC MARKETING PARTNERS LLC]

DAY CREAM MATTIFYING HYDRATOR

Ribavirin [Sandoz Inc]

These highlights do not include all the information needed to use RIBAVIRIN TABLETS safely and effectively. See full prescribing information for RIBAVIRIN TABLETS. Ribavirin Tablets, oralInitial U.S. ...

Ribavirin [Cadila Healthcare Limited]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

Ribavirin [Zydus Pharmaceuticals (USA) Inc.]

These highlights do not include all the information needed to use ribavirin safely and effectively. See full prescribing information for ribavirin. Initial U.S. Approval: 2002

PubMed Articles [231 Associated PubMed Articles listed on BioPortfolio]

Partners' Overestimation of Patients' Pain Severity: Relationships with Partners' Interpersonal Responses.

The present study examined whether concordance between patients' and their partners' reports of patient pain severity relates to partners' social support and behavioral responses in couples coping wit...

A qualitative study of secondary distribution of HIV self-test kits by female sex workers in Kenya.

Promoting awareness of serostatus and frequent HIV testing is especially important among high risk populations such as female sex workers (FSW) and their sexual partners. HIV self-testing is an approa...

Male engagement in women's microbicide use in Kenya: Navigating gender norms.

The success of women's microbicide use for HIV/AIDS prevention may hinge on health programs' ability to engage men to support it. In this qualitative study in Kenya, most women did not or would not te...

Psychological distress in men with prostate cancer and their partners before and after cancer diagnosis: a longitudinal study.

To examine the relative risk of psychological distress of men with prostate cancer and their partners during the period before and after prostate cancer diagnosis compared with men without prostate ca...

Partners of nulliparous women with severe fear of childbirth: A longitudinal study of psychological well-being.

Little is known about the psychological status of partners of women with severe fear of childbirth (FOC). In this longitudinal study from Helsinki University Central Hospital, we investigated FOC, dep...

Clinical Trials [248 Associated Clinical Trials listed on BioPortfolio]

Partners Demonstration Project of PrEP and ART

The purpose of this protocol is to determine user preferences for antiretroviral therapy (ART) for HIV-1 infected partners and pre-exposure prophylaxis (PrEP) HIV-1 un-infected partners an...

Teachers and Parents as Partners During Middle School

There are two aims of this study (a) to examine the effect of Teachers and Parents as Partners on student, parent, and teacher outcomes in middle school and (b) identify barriers and facil...

Treatment for Men Who Are Abusive to Their Partners

This study will develop an individual behavior therapy for men who are violent toward their partners and will compare the therapy to standard group treatment.

Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners

This pilot clinical trial studies how well acceptance and commitment therapy works in improving well-being in patients with stage III-IV cancer and their partners. Learning how to accept n...

Communication and Intimacy-Enhancing Therapy for Men With Early Stage Prostate Cancer and Their Partners

RATIONALE: Participating in a therapy program may enhance communication and intimacy between men with prostate cancer and their partners. PURPOSE: This randomized clinical trial is studyi...

Companies [888 Associated Companies listed on BioPortfolio]

Auriga Partners

Since 1998, AURIGA PARTNERS, an independent Venture Capital firm, has been managing several early stage funds specializing in Information Technology and Life Sciences. Enterprise creation represents ...

Auriga Laboratories

Auriga Laboratories™ is a specialty pharmaceutical company building an industry changing commission based-sales model. The company's high-growth business model combines driving revenues through a va...

Genocea Biosciences

Genocea Biosciences was founded in 2006 to commercialize key breakthroughs in vaccine discovery and development. The Company’s proprietary T cell-directed antigen disc...

SageCreek Partners

SageCreek Partners is creating and driving a new category of service: Mentor Capital. Working as a companion to technology companies and their investment partners and boards, Sage...

Health Partners Plans (HPP)

Nationally recognized for its innovations in managed care, Health Partners Plans consistently receives the highest ratings for member and provider satisfaction and, is currently r...

More Information about "Auriga Partners" on BioPortfolio

We have published hundreds of Auriga Partners news stories on BioPortfolio along with dozens of Auriga Partners Clinical Trials and PubMed Articles about Auriga Partners for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Auriga Partners Companies in our database. You can also find out about relevant Auriga Partners Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record